Moyamoya disease: A summary

Neurosurgical Focus

Volumn 26, Issue 4, 2009, Pages 1-10

  Burke, Gordon M ^a   Burke, Allan M ^b   Sherma, Arun K ^b   Hurley, Michael C ^b   Batjer, H Hunt ^b   Bendok, Bernard R ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cerebral angiography; Extracranial intracranial bypass; Moyamoya disease; Progressive intracranial occlusive arteriopathy

Indexed keywords

BRAIN; BRAIN ANGIOGRAPHY; BRAIN ARTERY; CEREBRAL REVASCULARIZATION; DIAGNOSTIC IMAGING; DISEASE COURSE; HUMAN; METHODOLOGY; MOYAMOYA DISEASE; NEOVASCULARIZATION (PATHOLOGY); ONSET AGE; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; REVIEW; TRANSPLANTATION; VASCULARIZATION;

AGE OF ONSET; BRAIN; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIES; CEREBRAL REVASCULARIZATION; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; MOYAMOYA DISEASE; NEOVASCULARIZATION, PATHOLOGIC; TRANSPLANTS;

EID: 70349728912     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2009.1.focus08310     Document Type: Review

References (78)

1. Adams HP Jr, Powers WJ, Grubb RL Jr, Clarke WR, Woolson RF: Preview of a new trial of extracranial-to-intracranial arterial anastomosis: the carotid occlusion surgery study. Neurosurg Clin N Am 12:613-624, 2001.
2. Aoki T, Matsuzawa H, Houkin K, Kamiyama H, Abe H, Miyasaka K, et al: [Usefulness and limitation of MR imaging and MR angiography in diagnosis of juvenile moyamoya disease.] No Shinkei Geka 21:305-311, 1993.
3. Aoyagi M, Fukai N, Yamamoto M, Matsushima Y, Yamamoto K: Development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Clin Neurol Neurosurg 99 (2 Suppl):S213-S217, 1997.
4. Baba T, Houkin K, Kuroda S: Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79:900-904, 2008.
5. Bonduel M, Hepner M, Sciuccati G, Torres AF, Tenembaum S: Prothrombotic disorders in children with moyamoya syndrome. Stroke 32:1786-1792, 2001.
6. Byval'tsev VA, Suzuki Y: [Combined treatment for Moya-Moya disease, by using direct anastomosis and revascularization: experience of 225 operations.] Zh Vopr Neirokhir Im N N Burdenko 3:11-16, 2007 (Russian).
7. Calamante F, Ganesan V, Kirkham FJ, Jan W, Chong WK, Gadian DG, et al: MR perfusion imaging in Moyamoya Syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke 32:2810-2816, 2001.
8. Cashen TA, Carr JC, Shin W, Walker MT, Futterer SF, Shaibani A, et al: Intracranial time-resolved contrast-enhanced MR angiography at 3T. AJNR Am J Neuroradiol 27:822-829, 2006.
9. Coakham HM, Duchen LW, Scaravilli F: Moya-moya disease: clinical and pathological report of a case with associated myopathy. J Neurol Neurosurg Psychiatry 42:289-297, 1979.
10. Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA: Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol 29:1228-1234, 2008.
11. Devous MD Sr, Lowe JL, Payne JK: Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: validation by phantom studies. J Nucl Med 33:2030-2035, 1992.
12. The EC/IC Bypass Study Group: Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313:1191-1200, 1985.
13. Fujii K, Ikezaki K, Irikura K, Miyasaka Y, Fukui M: The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clin Neurol Neurosurg 99 (2 Suppl): S194-S195, 1997.
14. Fujimura M, Kaneta T, Tominaga T: Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease. Childs Nerv Syst 24:827-832, 2008.
15. Fukui M: Current state of study on moyamoya disease in Japan. Surg Neurol 47:138-143, 1997.
16. Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research committee on spontaneous occlusion of the circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 (2 Suppl):S-38-S240, 1997.
17. Fukui M, Kono S, Sueishi K, Ikezaki K: Moyamoya disease. Neuropathology 20 (Suppl):S61-S64, 2000 (Fr).
18. Godin M, Tadie M, Dero J, Fillastre PJ, Creissard P: [Moya-Moya syndrome and renal artery stenosis (author's transl).] Sem Hop 56:1257-1261, 1980 (Fr).
19. Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT III, et al: Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37:1490-1496, 2006.
20. Herreman F, Nathal E, Yasui N, Yasuhiro Y: Intracranial aneurysms in moyamoya disease: report of ten cases and review of literature. Cerebrovasc Dis 4:329-336, 1994.
21. Hojo M, Hoshimaru M, Miyamoto S, Taki W, Nagata I, Asahi M, et al: Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg 89:623-629, 1998.
22. Hoshi H, Ohnishi T, Jinnouchi S, Futami S, Nagamachi S, Kodama T, et al: Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. J Nucl Med 35:44-50, 1994.
23. Hoshimaru M, Kikuchi H: Involvement of the external carotid arteries in moyamoya disease: neuroradiological evaluation of 66 patients. Neurosurgery 31:398-400, 1992.
24. Houkin K, Yoshimoto T, Kuroda S, Ishikawa T, Takahashi A, Abe H: Angiographic analysis of moyamoya disease-how does moyamoya disease progress? Neurol Med Chir (Tokyo) 36:783-788, 1996.
25. Ishii K, Isono M, Kobayashi H, Kamida T: Temporal profile of angiographical stages of moyamoya disease: when does moyamoya disease progress? Neurol Res 25:405-410, 2003.
26. Iwama T, Akiyama Y, Morimoto M, Kojima A, Hayashida K: Comparison of positron emission tomography study results of cerebral hemodynamics in patients with bleeding-and ischemic-type moyamoya disease. Neurosurg Focus 5(5):E3, 1998.
27. Kang KH, Kim HS, Kim SY: Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation. AJNR Am J Neuroradiol 29:1487-1493, 2008.
28. Kawaguchi S, Okuno S, Sakaki T: Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 93:397-401, 2000.
29. Kawaguchi S, Sakaki T, Morimoto T, Kakizaki T, Kamada K: Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases. Acta Neurochir Suppl 138:1287-1294, 1996.
30. Kawai M, Nishikawa T, Tanaka M, Ando A, Kasajima T, Higa T, et al: An autopsied case of Williams syndrome complicated by moyamoya disease. Acta Paediatr Jpn 35:63-67, 1993.
31. Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK: Progression of unilateral moyamoya disease: a clinical series. Cerebrovasc Dis 22:109-115, 2006.
32. Kikuta K: Experiences using 3-tesla magnetic resonance imaging in the treatment of Moyamoya disease. Acta Neurochir Suppl (Wien) 103:123-126, 2008.
33. Kohama M, Fujimura M, Mugikura S, Tominaga T: Temporal change of 3-T magnetic resonance imaging/angiography during symptomatic cerebral hyperperfusion following superficial temporal artery-middle cerebral artery anastomosis in a patient with adult-onset moyamoya disease. Neurosurg Rev 31:451-455, 2008.
34. Kono S, Oka K, Sueishi K: Histopathologic and morphometric studies of leptomeningeal vessels in moyamoya disease. Stroke 21:1044-1050, 1990.
35. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al: Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42-47, 2008.
36. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y: Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 38:1430-1435, 2007.
37. Kuroda S, Houkin K: Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056-1066, 2008.
38. Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Masuda K, Matsushima T, et al: Response to hypercapnia in moyamoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease. Stroke 28:701-707, 1997.
39. Kwak R, Emori T, Nakamura T, Kadoya S: [Significance of intracranial aneurysms associated with moyamoya disease. (Part II). Cause and site of hemorrhage-review of the literature.] Neurol Med Chir (Tokyo) 24:104-109, 1984 (Jpn).
40. Kwak R, Ito S, Yamamoto N, Kadoya S: [Significance of intracranial aneurysms associated with moyamoya disease. (Part I). Differences between intracranial aneurysms associated with moyamoya disease and usual saccular aneurysms-review of the literature.] Neurol Med Chir (Tokyo) 24:97-103, 1984 (Jpn).
41. Mandell DM, Han JS, Poublanc J, Crawley AP, Stainsby JA, Fisher JA, et al: Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI. Stroke 39:2021-2028, 2008.
42. Masuda J, Ogata J, Yamaguchi T: Moyamoya disease, in Mohr J, Choi D, Grotta J, Weir B, Wolf P (eds): Stroke: Pathophysiology, Diagnosis, and Management, ed 4. New York: Churchill Livingstone, 2004, pp 603-618.
43. Mesiwala AH, Sviri G, Fatemi N, Britz GW, Newell DW: Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus 24(2):E15, 2008.
44. Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, et al: Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70:2357-2363, 2008.
45. Miyamoto S: Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset-the Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo) 44:218-219, 2004.
46. Nagasaka T, Shiozawa Z, Kobayashi M, Shindo K, Tsunoda S, Amino A: Autopsy findings in Down's syndrome with cerebrovascular disorder. Clin Neuropathol 15:145-149, 1996.
47. Nanba R, Kuroda S, Ishikawa T, Houkin K, Iwasaki Y: Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke 35:2837-2842, 2004.
48. Nariai T, Matsushima Y, Imae S, Tanaka Y, Ishii K, Senda M, et al: Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study. J Neurol Neurosurg Psychiatry 76:663-669, 2005.
49. Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C: Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 29:625-630, 1998.
50. Osanai T, Kuroda S, Nakayama N, Yamauchi T, Houkin K, Iwasaki Y: Moyamoya disease presenting with subarachnoid hemorrhage localized over the frontal cortex: case report. Surg Neurol 69:197-200, 2008.
51. Ou P, Dupont P, Bonnet D: Fibromuscular dysplasia as the substrate for systemic and pulmonary hypertension in the setting of Moya-Moya disease. Cardiol Young 16:495-497, 2006.
52. Rao M, Zhang H, Liu Q, Zhang S, Hu L, Deng F: Clinical and experimental pathology of Moyamoya disease. Chin Med J (Engl) 116:1845-1849, 2003.
53. Reis CV, Safavi-Abbasi S, Zabramski JM, Gusmao SN, Spetzler RF, Preul MC: The history of neurosurgical procedures for moyamoya disease. Neurosurg Focus 20(6):E7, 2006.
54. Sakamoto S, Kiura Y, Yamasaki F, Shibukawa M, Ohba S, Shrestha P, et al: Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease. Neurosurg Rev 31:77-81, 2008.
55. Shimizu H, Shirane R, Fujiwara S, Takahashi A, Yoshimoto T: Proton magnetic resonance spectroscopy in children with moyamoya disease. Clin Neurol Neurosurg 99 (2 Suppl): S64-S67, 1997.
56. Smith ER, Scott RM: Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus 24(2):E17, 2008.
57. Soriano SG, Cowan DB, Proctor MR, Scott RM: Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. Neurosurgery 50:544-549, 2002.
58. Suyama K, Yoshida K, Takahata H, Toda K, Baba H, Ishikawa Y, et al: Pediatric moyamoya disease presenting with intracerebral hemorrhage-report of three cases and review of the literature. Clin Neurol Neurosurg 110:270-275, 2008.
59. Suzuki J, Kodama N: Moyamoya disease-a review. Stroke 14:104-109, 1983.
60. Suzuki J, Takaku A: Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288-299, 1969.
61. Takagi Y, Kikuta K, Nozaki K, Fujimoto M, Hayashi J, Imamura H, et al: Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with Moyamoya disease. Neurosurgery 60:338-345, 2007.
62. Takagi Y, Kikuta K, Nozaki K, Hashimoto N: Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol Med Chir (Tokyo) 47:1-4, 2007.
63. Takekawa Y, Umezawa T, Ueno Y, Sawada T, Kobayashi M: Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathology 24:236-242, 2004.
64. Taki W, Yonekawa Y, Kobayashi A, Ishikawa M, Kikuchi H, Nishizawa S, et al: Cerebral circulation and oxygen metabolism in moyamoya disease of ischemic type in children. Childs Nerv Syst 4:259-262, 1988.
65. Tanaka Y, Nariai T, Nagaoka T, Akimoto H, Ishiwata K, Ishii K, et al: Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging-comparison with positron emission tomography. J Cereb Blood Flow Metab 26:291-300, 2006.
66. Uchino K, Johnston SC, Becker KJ, Tirschwell DL: Moyamoya disease in Washington State and California. Neurology 65:956-958, 2005 67.
67. Vilela MD, Newell DW: Superficial temporal artery to middle cerebral artery bypass: past, present, and future. Neurosurg Focus 24(2):E2, 2008.
68. Wanifuchi H, Takeshita M, Izawa M, Aoki N, Kagawa M: Management of adult moyamoya disease. Neurol Med Chir (Tokyo) 33:300-305, 1993.
69. Woitzik J, Horn P, Vajkoczy P, Schmiedek P: Intraoperative control of extracranial-intracranial bypass patency by nearinfrared indocyanine green videoangiography. J Neurosurg 102:692-698, 2005.
70. Yamada H, Deguchi K, Tanigawara T, Takenaka K, Nishimura Y, Shinoda J, et al: The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg 99 (2 Suppl):S221-S224, 1997.
71. Yamada I, Suzuki S, Matsushima Y: Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography. Radiology 196:211-218, 1995.
72. Yamada M, Fujii K, Fukui M: [Clinical features and outcomes in patients with asymptomatic moyamoya disease-from the results of nation-wide questionnaire survey.] No Shinkei Geka 33:337-342, 2005 (Jpn).
73. Yamamoto M, Aoyagi M, Tajima S, Wachi H, Fukai N, Matsushima Y, et al: Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease. Stroke 28:1733-1738, 1997.
74. Yamashita M, Oka K, Tanaka K: Histopathology of the brain vascular network in moyamoya disease. Stroke 14:50-58, 1983.
75. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al: Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31:930-935, 2000.
76. Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y: Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: an extensive follow-up study. Stroke 30:2272-2276, 1999.
77. Yoshimoto T, Houkin K, Takahashi A, Abe H: Angiogenic factors in moyamoya disease. Stroke 27:2160-2165, 1996.
78. Zimmerman RA, Bilaniuk LT: 3T magnetic resonance arteriography in pediatric cerebrovascular disease. J Neuroradiol 34:95-100, 2007.